You are here
Alerts
This page shows all our alerts. These are Safety alerts, Medicine shortage alerts and Product recalls. You can sort the list with the filters on the left, use the search bar or both.
For more information see Product safety.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Alert/Advisory (1123)
- Medicines safety (501)
- Medical devices safety (342)
- Shortages (77)
- Safety (52)
- Prescription medicines (46)
- Regulatory compliance (18)
- Import and export (16)
- Listed medicines (14)
- Over the counter (OTC) medicines (12)
- Complementary medicines (10)
- Therapeutic goods regulation (10)
- Blood safety (8)
- Non-prescription medicines (6)
- Australian Register of Therapeutic Goods (ARTG) (5)
- Advertising (3)
- Sunscreens (3)
- Breast implant hub (2)
- Labelling and packaging (2)
- Legislation (2)
- Assessed listed medicines (1)
- Clinical trials (1)
- Compliance and enforcement hub (1)
- Metal-on-metal hip replacement implants hub (1)
- Registered complementary medicines (1)
Type of content
Results for
"[search-keyword]"
Search
1324 result(s) found, displaying 701 to 725
-
Recall for product correction - increased risk of death for patients with symptomatic chronic heart failure
-
Safety alerts
-
Ja Dera 100% Natural Weight Loss Supplement capsules pose a serious risk to your health and should not be taken
-
Safety alertsNo evidence to support routine blood monitoring at this time
-
Safety alertsSlim Fit capsules pose a serious risk to your health and should not be taken
-
Recall for product correction - additional affected devices
-
-
-
Recall - risk of adverse events due to unacceptably high level of arsenic
-
Safety alertsUpdate - adverse event monitoring
-
-
Recall for product correction - fire risk from faulty component
-
Recall for product correction - fire risk from faulty component
-
The following medicines (with brand names in brackets) should be returned to a pharmacy: alprazolam (Xanax), cabergoline (Dostinex and Cabaser), mefanamic acid (Ponstan), methotrexate (Methoblastin) and triazolam (Halcion)
-
Recall actionsRecall - bottles supplied without child-resistant caps
-
Medicine shortage - Immucyst and Oncotice
-
Recall for product correction - risk of sparking or fire due to damaged or cut wire
-
-
Recall for product correction - potential for insulin to not be delivered as intended
-
Recall - counterfeit products may have defects and not be effective
-
-
Recall actionsUpdate - recall for product correction - advertisements published to inform all affected users
-
-
-